The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Healthy Adult Volunteers Volunteers

NCT03707899 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

49

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension With Dyslipidemia

Interventions

DRUG: JLP-1401
DRUG: Telmisartan/Amlodipine, Rosuvastatin

Sponsor

Jeil Pharmaceutical Co., Ltd.